Evidence map›Paper›PMID 39899643›Full record

ArticlePLoS computational biology2025

RSero: A user-friendly R package to reconstruct pathogen circulation history from seroprevalence studies.

Nathanaël Hozé, Margarita Pons-Salort, C Jessica E Metcalf, Michael White, Henrik Salje, Simon Cauchemez

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nathanaël HozéMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, U1332 INSERM, UMR2000 CNRS, Paris, France.ORCID 0000-0002-3977-8966
Margarita Pons-SalortMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.ORCID 0000-0001-5597-9285
C Jessica E MetcalfDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, New Jersey, United States of America.
Michael WhiteDepartment of Global Health, Infectious Disease Epidemiology and Analytics G5 Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Henrik SaljeDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.
Simon CauchemezMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, U1332 INSERM, UMR2000 CNRS, Paris, France.

Funding

Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central AfricaU01AI151758 · NIAID · INSTITUT PASTEUR · PI SAKUNTABHAI, ANAVAJ, SIMON-LORIERE, ETIENNE · 2020 to 2024
$6.7M
Defining correlates of protection from dengue illness in a long-term cohort study of multigenerational house-holds in ThailandR01AI175941 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI Kathryn B Anderson · 2023 to 2026
$2.7M
NIAID NIH HHS R01 AI175941NIAID NIH HHS U01 AI151758Wellcome Trust
6 · The paper itself

Abstract

Population-based serological surveys are a key tool in epidemiology to characterize the level of population immunity and reconstruct the past circulation of pathogens. A variety of serocatalytic models have been developed to estimate the force of infection (FOI) (i.e., the rate at which susceptible individuals become infected) from age-stratified seroprevalence data. However, few tool currently exists to easily implement, combine, and compare these models. Here, we introduce an R package, Rsero, that implements a series of serocatalytic models and estimates the FOI from age-stratified seroprevalence data using Bayesian methods. The package also contains a series of features to perform model comparison and visualise model fit. We introduce new serocatalytic models of successive outbreaks and extend existing models of seroreversion to any transmission model. The different features of the package are illustrated with simulated and real-life data. We show we can identify the correct epidemiological scenario and recover model parameters in different epidemiological settings. We also show how the package can support serosurvey study design in a variety of epidemic situations. This package provides a standard framework to epidemiologists and modellers to study the dynamics of past pathogen circulation from cross-sectional serological survey data.

Indexed as

Computational BiologySoftwareBayes TheoremComputer SimulationDisease OutbreaksEpidemiological ModelsHumansSeroepidemiologic Studies

Identifiers

PMID39899643
PMCPMC11809794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.